# Patient Assistance Program

**Mark Egly Foundation**
**Document Version:** 1.0
**Effective Date:** November 10, 2025
**Document Owner:** Director of Patient Services
**Review Cycle:** Annually (or when funding changes significantly)
**Related Documents:**

- Grant Management & Reporting
- Financial Management & 501(c)(3) Compliance
- HIPAA Implementation Playbook
- Patient Navigation Program
- Treatment Options Guide

---

## Table of Contents

1. [Philosophy & Mission Alignment](#philosophy--mission-alignment)
2. [Program Overview](#program-overview)
3. [Types of Assistance Offered](#types-of-assistance-offered)
4. [Eligibility Requirements](#eligibility-requirements)
5. [Application Process](#application-process)
6. [Review & Approval Workflow](#review--approval-workflow)
7. [Payment & Distribution Methods](#payment--distribution-methods)
8. [Funding Sources & Sustainability](#funding-sources--sustainability)
9. [Partnerships with Industry Programs](#partnerships-with-industry-programs)
10. [Privacy & Confidentiality](#privacy--confidentiality)
11. [Fraud Prevention & Compliance](#fraud-prevention--compliance)
12. [Annual Budget & Allocation](#annual-budget--allocation)
13. [Impact Measurement & Reporting](#impact-measurement--reporting)
14. [Appeals & Grievance Process](#appeals--grievance-process)
15. [Program Marketing & Outreach](#program-marketing--outreach)
16. [Success Stories & Testimonials](#success-stories--testimonials)
17. [Continuous Improvement](#continuous-improvement)

---

## Philosophy & Mission Alignment

### Why Patient Assistance Matters

The Mark Egly Foundation's mission is to end diagnostic delays and improve outcomes for AATD patients. Financial barriers represent one of the most significant obstacles to achieving this mission:

**The Financial Burden of AATD:**

- **Genetic testing**: $200-$1,500 (often not covered by insurance)
- **Augmentation therapy**: $100,000-200,000 annually (with 20% co-pays = $20,000-$40,000 out of pocket)
- **Specialist visits**: Multiple pulmonologists, hepatologists, genetic counselors
- **Travel costs**: Patients in rural areas may travel 100+ miles to AATD specialists
- **Lost wages**: Time off for appointments, procedures, and illness
- **Emergency interventions**: Hospitalizations for exacerbations

**Without financial assistance:**

- Patients delay or skip genetic testing (remain undiagnosed)
- Patients cannot afford augmentation therapy (disease progression accelerates)
- Families face medical bankruptcy
- Health disparities widen (low-income patients suffer worse outcomes)

### Guiding Principles

**1. No Patient Left Behind**

- Financial circumstances should never prevent access to life-saving diagnosis and treatment
- Assistance is available to all qualifying patients regardless of race, ethnicity, gender, religion, or geography

**2. Dignity & Respect**

- Application process is streamlined and compassionate
- Patients are not required to share excessive personal financial details
- Assistance is provided confidentially without stigma

**3. Stewardship & Accountability**

- Foundation funds are used responsibly and transparently
- Assistance goes directly to medical costs (not redirected)
- Fraud prevention measures protect donor contributions
- Impact is measured and reported to stakeholders

**4. Collaboration, Not Duplication**

- Partner with pharmaceutical patient assistance programs (PAPs)
- Connect patients to all available resources (government programs, co-pay assistance, etc.)
- Fill gaps where other programs fall short

**5. Empowerment & Education**

- Teach patients to navigate the healthcare system
- Provide tools for self-advocacy
- Support long-term financial sustainability (not just one-time assistance)

---

## Program Overview

### Mission Statement

The Mark Egly Foundation Patient Assistance Program provides financial support to AATD patients for genetic testing, treatment costs, and related medical expenses to ensure timely diagnosis and access to optimal care.

### Program Goals

**Primary Objectives:**

1. **Eliminate testing barriers**: 100% of patients who need genetic testing receive it
2. **Support treatment access**: Reduce treatment abandonment due to cost
3. **Accelerate diagnosis**: Shorten time from symptom onset to confirmed diagnosis
4. **Reduce health disparities**: Ensure low-income patients have equal access
5. **Improve outcomes**: Patients receiving assistance show improved health metrics

**Annual Targets (Year 1):**

- Assist 100 patients with genetic testing
- Support 25 patients with augmentation therapy co-pays
- Provide travel assistance to 50 patients
- Emergency assistance to 10 patients
- Total patients served: 185 (with some receiving multiple types of assistance)

### Program Scope

**What We Fund:**

- ‚úÖ Genetic testing for AATD (serum AAT levels, phenotyping, genotyping)
- ‚úÖ Augmentation therapy co-pays and deductibles
- ‚úÖ Travel costs for medical appointments (mileage, lodging, meals)
- ‚úÖ Specialist consultation co-pays
- ‚úÖ Pulmonary function testing
- ‚úÖ Hepatology screening and monitoring
- ‚úÖ Emergency medical assistance (hospitalization co-pays)
- ‚úÖ Durable medical equipment (oxygen concentrators, nebulizers)

**What We Do NOT Fund:**

- ‚ùå Non-AATD-related medical expenses
- ‚ùå Elective procedures or cosmetic treatments
- ‚ùå Over-the-counter supplements or vitamins
- ‚ùå Legal fees or advocacy services (separate program)
- ‚ùå Retroactive reimbursement (assistance must be approved before expense incurred)
- ‚ùå Expenses already covered by insurance or other assistance programs

---

## Types of Assistance Offered

### 1. Genetic Testing Assistance

**Purpose**: Remove financial barriers to AATD diagnosis

**Covered Tests:**

- **Serum AAT Level Test**: Measures alpha-1 antitrypsin protein in blood ($50-$150)
- **Phenotype Test**: Identifies protein variants (Pi types) ($100-$300)
- **Genotype Test**: DNA analysis for specific mutations (PiZZ, PiSZ, PiMZ, rare variants) ($200-$1,500)
- **Confirmatory Testing**: Second opinion or specialized genetic testing

**Eligibility:**

- Physician recommendation or clinical suspicion of AATD
- Symptoms consistent with AATD (COPD, emphysema, liver disease, bronchiectasis)
- Family history of AATD
- Uninsured or underinsured (insurance denial or high deductible)

**Assistance Level:**

- Up to $1,500 per patient for comprehensive genetic testing
- Covers full cost of test if uninsured
- Covers co-pays, deductibles, or out-of-pocket costs if insured

**Annual Budget Allocation**: $150,000 (100 patients √ó $1,500 average)

---

### 2. Augmentation Therapy Co-Pay Assistance

**Purpose**: Ensure patients can afford AAT replacement therapy (IV infusions)

**Covered Expenses:**

- Monthly or quarterly co-pays for augmentation therapy
- Deductibles at start of insurance year
- Coinsurance (percentage of total cost)
- Out-of-pocket maximum contributions

**Eligibility:**

- Confirmed AATD diagnosis (Pi*ZZ, Pi*SZ, or other severe deficiency genotypes)
- Physician-prescribed augmentation therapy
- Commercial insurance (not Medicare or Medicaid - see restrictions below)
- Demonstrated financial need (income <400% federal poverty level)
- Patient is actively receiving therapy (not discontinued)

**Assistance Level:**

- Up to $10,000 per patient per year
- Maximum 2 consecutive years (then re-application required)
- Paid directly to pharmacy or infusion center (not to patient)

**Restrictions:**

- **Cannot assist Medicare/Medicaid patients**: Federal anti-kickback laws prohibit foundations from subsidizing government program beneficiaries
- **Must use approved therapies**: Prolastin, Aralast, Glassia, Zemaira (FDA-approved AAT products)

**Annual Budget Allocation**: $250,000 (25 patients √ó $10,000)

---

### 3. Travel Assistance

**Purpose**: Help patients reach specialized AATD care centers

**Covered Expenses:**

- **Mileage Reimbursement**: $0.67/mile (IRS medical mileage rate for 2025)
- **Public Transportation**: Bus, train, or air fare (coach class)
- **Lodging**: Hotel for overnight stays ($100/night max, 2 nights max per trip)
- **Meals**: Per diem of $30/day during travel
- **Parking and Tolls**: Actual costs with receipts

**Eligibility:**

- Patient must travel >50 miles one-way to AATD specialist or infusion center
- Appointment confirmed with provider
- No local alternatives available
- Financial need demonstrated

**Assistance Level:**

- Up to $500 per trip
- Maximum 4 trips per year ($2,000 total per patient)
- Advance approval required for air travel or lodging

**Annual Budget Allocation**: $100,000 (50 patients √ó $2,000)

---

### 4. Specialist Co-Pay Assistance

**Purpose**: Cover out-of-pocket costs for AATD-related medical appointments

**Covered Services:**

- Pulmonologist visits
- Hepatologist consultations
- Genetic counselor sessions
- Respiratory therapist evaluations
- Diagnostic imaging (CT scans, X-rays, ultrasounds)
- Pulmonary function tests (PFTs)
- Liver biopsy or FibroScan procedures

**Eligibility:**

- Confirmed or suspected AATD diagnosis
- Service is medically necessary and AATD-related
- Insurance requires co-pay or service not covered
- Financial hardship

**Assistance Level:**

- Up to $100 per visit co-pay
- Maximum $1,000 per patient per year
- Requires proof of appointment and billing statement

**Annual Budget Allocation**: $50,000 (50 patients √ó $1,000)

---

### 5. Emergency Medical Assistance

**Purpose**: Provide rapid financial support during medical crises

**Covered Emergencies:**

- Hospitalization for AATD exacerbation (COPD flare, respiratory failure)
- Emergency room visits for respiratory distress
- Urgent liver-related complications
- Post-surgical care related to AATD (lung transplant recovery, etc.)

**Eligibility:**

- Confirmed AATD diagnosis
- Medical emergency directly related to AATD
- Patient or family facing immediate financial hardship
- Unable to pay hospital bills or co-pays

**Assistance Level:**

- Up to $5,000 per emergency event
- One-time assistance (rare exceptions for extraordinary circumstances)
- Expedited approval within 48-72 hours

**Annual Budget Allocation**: $50,000 (10 patients √ó $5,000)

---

### 6. Durable Medical Equipment (DME) Assistance

**Purpose**: Help patients obtain medical equipment needed for AATD management

**Covered Equipment:**

- Oxygen concentrators (home and portable)
- CPAP or BiPAP machines
- Nebulizers and compressors
- Pulse oximeters
- Peak flow meters
- Mobility aids (walkers, wheelchairs if respiratory compromise limits mobility)

**Eligibility:**

- Physician prescription for equipment
- Insurance denial or inadequate coverage
- Equipment directly related to AATD management

**Assistance Level:**

- Up to $2,000 per patient per year
- Preference for purchasing equipment (vs. rental) for long-term cost savings
- May assist with maintenance or replacement of existing equipment

**Annual Budget Allocation**: $30,000 (15 patients √ó $2,000)

---

## Eligibility Requirements

### General Eligibility Criteria

To qualify for any Mark Egly Foundation patient assistance, applicants must meet **ALL** of the following:

**1. Medical Criteria:**

- [ ] Confirmed AATD diagnosis (Pi*ZZ, Pi*SZ, Pi\*MZ, or other deficiency variants)
- [ ] OR strong clinical suspicion of AATD (for genetic testing assistance only)
- [ ] Physician documentation of AATD or request for testing
- [ ] Medical necessity of requested assistance

**2. Financial Criteria:**

- [ ] Demonstrated financial need (see income guidelines below)
- [ ] Uninsured, underinsured, or facing high out-of-pocket costs
- [ ] Unable to afford expense without assistance
- [ ] Exhausted other available resources (insurance, manufacturer PAPs, government programs)

**3. Residency Criteria:**

- [ ] United States resident (50 states, DC, Puerto Rico, US territories)
- [ ] Proof of residency (utility bill, lease, driver's license)

**4. Administrative Criteria:**

- [ ] Complete application submitted
- [ ] Required documentation provided
- [ ] Signed consent forms (HIPAA, program terms)
- [ ] Compliance with program rules

### Income Guidelines

Financial need is assessed using **Federal Poverty Level (FPL)** guidelines. Priority is given to patients with greatest need:

**Tier 1: Highest Priority (0-200% FPL)**

- Income below 200% of federal poverty level
- Eligible for maximum assistance
- Streamlined application process

**Tier 2: Moderate Priority (201-300% FPL)**

- Income 201-300% of federal poverty level
- Eligible for substantial assistance
- Standard application process

**Tier 3: Lower Priority (301-400% FPL)**

- Income 301-400% of federal poverty level
- Eligible for limited assistance (if funds available)
- May require additional documentation of hardship

**Above 400% FPL:**

- Generally not eligible unless exceptional circumstances
- Examples: catastrophic medical debt, job loss, single-income family with multiple dependents

**2025 Federal Poverty Levels (Continental US):**

| Household Size | 100% FPL | 200% FPL | 300% FPL | 400% FPL |
| -------------- | -------- | -------- | -------- | -------- |
| 1              | $15,060  | $30,120  | $45,180  | $60,240  |
| 2              | $20,440  | $40,880  | $61,320  | $81,760  |
| 3              | $25,820  | $51,640  | $77,460  | $103,280 |
| 4              | $31,200  | $62,400  | $93,600  | $124,800 |
| 5              | $36,580  | $73,160  | $109,740 | $146,320 |
| 6              | $41,960  | $83,920  | $125,880 | $167,840 |
| 7              | $47,340  | $94,680  | $142,020 | $189,360 |
| 8              | $52,720  | $105,440 | $158,160 | $210,880 |

_Add $5,380 for each additional household member_

### Special Circumstances

**Hardship Exceptions:**
Even if income exceeds guidelines, assistance may be granted for:

- Recent job loss or income reduction
- Catastrophic medical expenses (>20% of annual income)
- Multiple dependents with special needs
- Single-income households
- Recent bankruptcy or foreclosure
- Domestic violence or family crisis

**Documentation Required:**

- Termination notice or unemployment benefits letter
- Medical bills totaling >20% income
- Dependent information and special needs documentation
- Bankruptcy discharge papers
- Police report or protective order

---

## Application Process

### Step-by-Step Application Guide

#### Step 1: Pre-Application Assessment (5 minutes)

**Online Self-Assessment Tool:**
Visit: markeglyfoundation.org/patient-assistance

Answer simple questions:

1. Do you have confirmed or suspected AATD?
2. What type of assistance do you need?
3. What is your approximate household income?
4. Do you have health insurance?
5. Have you applied to other assistance programs?

**Instant Result:**

- "You appear to be eligible! Click here to start your application."
- "You may be eligible, but we need more information. Click here to apply."
- "Based on your responses, you may not qualify, but we encourage you to contact us at [phone] to discuss your situation."

#### Step 2: Gather Required Documents

**All Applications Require:**

- [ ] **Physician Statement**: Letter from doctor confirming AATD diagnosis or need for testing
- [ ] **Proof of Income**: Recent pay stubs (2 months), tax return (most recent), or SNAP/Medicaid eligibility letter
- [ ] **Proof of Residency**: Utility bill, lease, driver's license, or voter registration card
- [ ] **Insurance Card** (if insured): Front and back copy

**Type-Specific Documents:**

**For Genetic Testing:**

- [ ] Lab requisition or test order from physician
- [ ] Insurance denial letter (if applicable)
- [ ] Estimate of test cost

**For Augmentation Therapy:**

- [ ] Prescription for AAT replacement therapy
- [ ] Insurance Explanation of Benefits (EOB) showing co-pay amount
- [ ] Pharmacy or infusion center contact information

**For Travel Assistance:**

- [ ] Appointment confirmation (date, time, location)
- [ ] Distance calculation (Google Maps screenshot)
- [ ] Itinerary for travel and lodging

**For Emergency Assistance:**

- [ ] Hospital bill or ER discharge summary
- [ ] Documentation of emergency AATD-related event

#### Step 3: Complete Online Application (15-30 minutes)

**Application Portal:**
Secure, HIPAA-compliant online form at: markeglyfoundation.org/apply

**Sections:**

1. **Personal Information**: Name, DOB, address, phone, email
2. **Medical Information**: AATD genotype, diagnosis date, symptoms, current treatment
3. **Physician Information**: Doctor's name, practice, contact info
4. **Financial Information**: Household size, income, expenses
5. **Insurance Information**: Carrier, policy number, coverage details
6. **Assistance Request**: Type of assistance, amount requested, justification
7. **Other Resources**: Have you applied to manufacturer PAPs? Government programs?
8. **Document Upload**: Attach all required documents (PDF, JPG, PNG accepted)
9. **Consent & Signature**: Electronic signature, date

**Accessibility:**

- Spanish language version available
- Phone application assistance: 1-800-XXX-XXXX (M-F 9am-5pm ET)
- Paper applications mailed upon request (for those without internet access)

#### Step 4: Submit & Confirmation

**Submission:**

- Click "Submit Application"
- Receive confirmation email immediately
- Application ID number for tracking (save this!)

**What Happens Next:**

- Application reviewed within 5-10 business days (standard)
- Emergency requests reviewed within 48-72 hours
- May request additional documentation if needed
- Notification of decision via email and phone

#### Step 5: Track Application Status

**Patient Portal:**
Log in at: markeglyfoundation.org/portal

**Status Updates:**

- ‚úÖ **Received**: Application submitted successfully
- üìã **Under Review**: Staff reviewing your application
- ‚ùì **Additional Info Needed**: Check email for request
- ‚úÖ **Approved**: Assistance granted! Payment processing.
- ‚ùå **Denied**: See reason and appeals process
- üí∞ **Payment Issued**: Check mailed or payment sent to provider

---

## Review & Approval Workflow

### Review Team Structure

**Tier 1: Initial Screening (Patient Services Coordinator)**

- Reviews application for completeness
- Verifies eligibility criteria met
- Checks for duplicates or fraud indicators
- Timeline: 2-3 business days

**Tier 2: Financial & Medical Review (Program Manager)**

- Assesses financial need based on income guidelines
- Reviews medical necessity with physician statements
- Determines appropriate assistance level
- Checks availability of funds in budget category
- Timeline: 3-5 business days

**Tier 3: Final Approval (Director of Patient Services)**

- Approves all assistance >$2,500
- Reviews complex or unusual cases
- Ensures compliance with program policies
- Timeline: 1-2 business days

**Emergency Review Track:**

- All three tiers compressed into 48-72 hours
- Emergency contact number for urgent cases
- After-hours approval authority for Director

### Decision Criteria

**Approval Factors:**
‚úÖ Meets all eligibility requirements
‚úÖ Compelling medical need (physician support)
‚úÖ Demonstrated financial hardship
‚úÖ Exhausted other resources
‚úÖ Complete and accurate application
‚úÖ Funds available in budget category
‚úÖ Patient compliant with program terms

**Denial Factors:**
‚ùå Does not meet medical criteria (no AATD diagnosis or suspicion)
‚ùå Income exceeds guidelines without hardship exception
‚ùå Incomplete application or missing documents
‚ùå Expense already covered by insurance or other program
‚ùå Retroactive reimbursement requested (must apply BEFORE expense)
‚ùå Non-AATD-related medical expense
‚ùå Fraudulent information provided
‚ùå Budget exhausted for fiscal year

### Approval Notifications

**Approval Letter Includes:**

- Congratulations message
- Assistance type and amount approved
- Payment method and timeline
- Terms and conditions of assistance
- Reporting requirements (if applicable)
- Contact information for questions
- Gratitude to donors who made assistance possible

**Denial Letter Includes:**

- Reason for denial (specific and clear)
- Appeals process information
- Alternative resources and referrals
- Encouragement to reapply if circumstances change
- Contact information for questions

---

## Payment & Distribution Methods

### Payment Methods by Assistance Type

**1. Direct Payment to Provider (Preferred Method)**

- **Use For**: Augmentation therapy co-pays, genetic testing, specialist visits, DME
- **Process**:
  1. Patient provides provider billing information
  2. Foundation contacts provider to verify service and cost
  3. Foundation issues check or EFT directly to provider
  4. Provider applies payment to patient account
  5. Patient receives zero bill or reduced bill

**Benefits:**

- Ensures funds used for intended purpose
- Reduces fraud risk
- Simpler tax reporting
- Patient not responsible for managing large sums

**2. Reimbursement to Patient**

- **Use For**: Travel expenses (mileage, meals, parking)
- **Process**:
  1. Patient incurs expense and keeps receipts
  2. Patient submits reimbursement form with receipts
  3. Foundation reviews and approves within 5 business days
  4. Check mailed to patient

**Requirements:**

- Original receipts required (photos accepted)
- Reimbursement form signed and dated
- Must submit within 90 days of expense
- Maximum processing time: 10 business days

**3. Prepaid Card (For Travel Assistance)**

- **Use For**: Travel, lodging, meals for out-of-town appointments
- **Process**:
  1. Foundation loads prepaid Visa card with approved amount
  2. Card mailed to patient prior to travel
  3. Patient uses card for approved expenses
  4. Patient submits receipts and unused balance returned

**Benefits:**

- Patient doesn't need to front money
- Real-time tracking of expenses
- Easy to reload if additional assistance approved

**4. Third-Party Payment Platforms**

- **Use For**: Emergency assistance, urgent needs
- **Process**:
  1. Foundation uses Zelle, Venmo, PayPal to send funds quickly
  2. Patient receives funds within hours
  3. Patient submits receipts showing use for approved purpose

**Use Sparingly:**

- Higher fraud risk
- Less accountability
- Only for time-sensitive emergencies

### Payment Timeline

| Assistance Type        | Review Time | Payment Processing   | Total Timeline |
| ---------------------- | ----------- | -------------------- | -------------- |
| Genetic Testing        | 5-10 days   | 3-5 days             | 8-15 days      |
| Augmentation Therapy   | 5-10 days   | 3-5 days             | 8-15 days      |
| Travel (Reimbursement) | 5 days      | 5-10 days            | 10-15 days     |
| Travel (Prepaid Card)  | 5 days      | 5-7 days (mail time) | 10-12 days     |
| Emergency              | 48-72 hours | 24-48 hours          | 3-5 days       |
| Specialist Co-Pay      | 5-7 days    | 3-5 days             | 8-12 days      |
| DME                    | 7-10 days   | 5-7 days             | 12-17 days     |

**Expedited Processing:**

- Available for urgent medical needs
- Must provide documentation of urgency
- Additional $25 wire transfer fee (waived for patients)

---

## Funding Sources & Sustainability

### Revenue Streams for Patient Assistance

**1. Individual Donor Contributions**

- Annual Fund campaigns specifically earmarked for patient assistance
- Major donor restricted gifts
- Planned giving and bequests
- Online fundraising campaigns (#HelpAATDPatients)

**Target**: $300,000/year (50% of total budget)

**2. Corporate & Foundation Grants**

- Pharmaceutical company educational grants (unrestricted)
- Health-focused foundations (NORD, PCORI, Robert Wood Johnson)
- Community foundations (local health initiatives)
- Corporate giving programs (matching employee donations)

**Target**: $200,000/year (33% of total budget)

**3. Fundraising Events**

- Annual gala with patient assistance fund highlighted
- Golf tournament benefiting patient programs
- Peer-to-peer fundraising (patients raise funds to help others)

**Target**: $100,000/year (17% of total budget)

**4. Endowment Earnings** (Future Goal)

- Build $2 million endowment for patient assistance
- 4-5% spending rate = $80,000-$100,000 annually
- Provides sustainable funding indefinitely

**Target**: Long-term (Years 3-5)

### Budget Sustainability Strategies

**Tiered Funding Approach:**

- **Tier 1 (Essential)**: Genetic testing assistance - $150,000 (funded first)
- **Tier 2 (Core)**: Augmentation therapy co-pays - $250,000 (high priority)
- **Tier 3 (Supportive)**: Travel, co-pays, DME - $180,000 (funded if available)
- **Tier 4 (Responsive)**: Emergency assistance - $50,000 (reserve fund)

**If Budget Shortfall:**

- Prioritize Tier 1 and 2 first
- Reduce assistance amounts rather than eliminate programs
- Implement waitlist for non-urgent assistance
- Increase fundraising efforts for specific programs

**Fund Reserves:**

- Maintain 3-6 months operating reserve ($150,000-$300,000)
- Allows continuation during funding gaps
- Board-designated fund for patient assistance

### Donor Stewardship for Patient Assistance Funds

**Transparency:**

- Annual report shows exactly how patient assistance funds were used
- Aggregated patient stories (anonymized)
- "Your donation helped 100 patients get genetic testing" messaging

**Recognition:**

- Patient Assistance Fund Honor Roll (donors ‚â•$1,000)
- Named funds for major donors ($25,000+): "The [Donor Name] AATD Testing Fund"
- Patient testimonials thanking donors (with patient consent)

**Impact Reports:**

- Quarterly updates to patient assistance donors
- Metrics: Patients served, lives changed, health outcomes improved
- Video stories from patients (with consent)

---

## Partnerships with Industry Programs

### Pharmaceutical Patient Assistance Programs (PAPs)

The Mark Egly Foundation works in **coordination** (not competition) with industry PAPs:

**Major AAT Manufacturer Programs:**

**1. Grifols Patient Assistance Program**

- Product: Prolastin-C
- Website: prolastin.com/patient-resources
- Phone: 1-888-PROLASTIN
- Eligibility: Uninsured or underinsured, income ‚â§500% FPL
- Coverage: Free medication for eligible patients

**2. CSL Behring Patient Assistance**

- Product: Zemaira
- Website: zemaira.com/patient-support
- Phone: 1-877-355-5111
- Eligibility: Commercial insurance patients with co-pay burden
- Coverage: Co-pay assistance up to $12,000/year

**3. Takeda (Shire) Cares Program**

- Product: Glassia
- Website: glassia.com/patient-support
- Phone: 1-888-229-8379
- Eligibility: Insured patients
- Coverage: Co-pay cards, patient navigation, reimbursement support

**4. Grifols AlphaCare Program**

- Product: Aralast NP
- Website: aralast.com/patients
- Phone: 1-888-4-ARALAST
- Eligibility: Varies by need
- Coverage: Reimbursement support, financial assistance

### Foundation's Role: Filling the Gaps

**Gap 1: Patients Who Don't Qualify for PAPs**

- Income too high for free medication but still can't afford co-pays
- Medicare/Medicaid patients (PAPs often restricted)
- Patients between insurance coverage (job transition, COBRA gap)

**Foundation Assistance**: Bridge funding during coverage gaps

**Gap 2: Non-Medication Costs**

- Genetic testing (before therapy prescribed)
- Specialist visits to establish therapy need
- Monitoring tests (PFTs, liver function)
- Travel to infusion centers

**Foundation Assistance**: Comprehensive support beyond medication

**Gap 3: Multiple Simultaneous Expenses**

- Patient may receive free medication from PAP but still face:
  - Travel costs
  - Lost wages
  - Co-pays for monitoring visits
  - DME costs

**Foundation Assistance**: Holistic support for total cost of care

### Referral Partnership Process

**Step 1: Foundation Screens for PAP Eligibility**

- Every patient assistance applicant is assessed for PAP eligibility
- If eligible, Foundation refers to appropriate PAP first
- Provides application assistance if patient needs help

**Step 2: PAP Application Support**

- Foundation patient navigators help patients complete PAP applications
- Follow up to ensure applications processed
- Advocate for patients if applications denied

**Step 3: Foundation Assistance AFTER PAP**

- Patient must apply to relevant PAPs before Foundation assistance considered
- Foundation provides supplemental assistance for costs NOT covered by PAP
- OR provides assistance during PAP application processing time

**Step 4: Ongoing Coordination**

- Foundation communicates with PAPs to avoid duplication
- Shares resources and best practices
- Collaborates on patient success stories (with consent)

### Co-Pay Accumulator Program Challenges

**The Problem:**

- Insurance co-pay accumulator programs prevent manufacturer co-pay cards from counting toward deductible
- Patient receives co-pay assistance but still must pay full deductible
- Can result in $10,000+ out-of-pocket expenses despite "assistance"

**Foundation's Response:**

- Advocate against co-pay accumulator programs (policy work)
- Provide assistance to patients caught in accumulator programs
- Educate patients about accumulator risks when selecting insurance plans

---

## Privacy & Confidentiality

### HIPAA Compliance

**Protected Health Information (PHI) Collected:**

- Patient name, address, date of birth
- AATD diagnosis and genotype
- Physician information and medical documentation
- Insurance information
- Financial information (income, expenses)

**Safeguards:**

- **Encryption**: All online applications use 256-bit SSL encryption
- **Access Controls**: Only authorized staff (Patient Services team) access applications
- **Secure Storage**: Paper files in locked cabinets, electronic files on secure servers
- **Data Retention**: Applications retained for 7 years per IRS requirements, then securely destroyed
- **Business Associate Agreements**: Any vendors handling PHI must sign BAAs

**Patient Rights:**

- Right to access their own application and records
- Right to request amendments to inaccurate information
- Right to accounting of disclosures
- Right to file complaint if privacy violated

### Confidentiality of Assistance

**Public Disclosure:**

- ‚ùå Patient names and assistance amounts NEVER publicly disclosed
- ‚ùå Individual patient information not shared with donors (even major donors)
- ‚úÖ Aggregate statistics shared (e.g., "We helped 100 patients with testing")
- ‚úÖ Anonymized success stories shared (first name only, no identifying details)

**Patient Consent for Stories:**

- Written consent required before sharing any patient story
- Patient reviews and approves final story before publication
- Patient can withdraw consent at any time
- Compensation not provided for stories (avoid perception of coercion)

**Exceptions to Confidentiality:**

- Legal requirement (court order, subpoena)
- Fraud investigation (suspected misuse of funds)
- Mandatory reporting (child abuse, elder abuse)
- Patient authorizes release (written consent)

---

## Fraud Prevention & Compliance

### Fraud Prevention Measures

**Application Verification:**

- [ ] Physician contact information verified (call office to confirm)
- [ ] Income documentation checked (pay stubs match employer, tax returns signed by CPA)
- [ ] Insurance cards verified (call insurer to confirm coverage)
- [ ] Medical necessity reviewed (symptoms consistent with diagnosis)
- [ ] Cross-check against previous applications (no duplicates)

**Red Flags for Fraud:**

- üö© Physician cannot be reached or doesn't know patient
- üö© Income documents appear altered or forged
- üö© Patient requests cash payment instead of provider payment
- üö© Multiple applications from same IP address with different names
- üö© Reluctance to provide documentation
- üö© Story changes between application and follow-up calls
- üö© Urgency pressure ("I need money today or I'll die")

**Investigation Process:**

1. Flag suspicious application (do not approve payment)
2. Request additional documentation
3. Conduct independent verification (call physician, check insurance)
4. If fraud suspected, consult legal counsel
5. Deny application and document reason
6. Report to law enforcement if criminal fraud suspected

**Consequences of Fraud:**

- Application denied
- Banned from future assistance (permanent)
- Required to repay any assistance received (civil action)
- Criminal prosecution if appropriate (theft by deception)
- Reported to other patient assistance programs (prevent serial fraud)

### Compliance with Federal Regulations

**Anti-Kickback Statute (Medicare/Medicaid):**

- Foundation CANNOT provide assistance to Medicare/Medicaid beneficiaries for co-pays
- Violates federal law (indirect inducement to use particular provider or product)
- Foundation may assist with non-covered services only (travel, testing not covered by Medicare)

**IRS Charitable Purpose Requirements:**

- Assistance must serve charitable purpose (helping needy individuals)
- Cannot primarily benefit private interests (drug companies, providers)
- Must assess financial need (can't give to wealthy individuals)
- Documentation requirements: Applications, approval records, payment records

**State Charitable Solicitation Laws:**

- Funds raised for patient assistance must be used for patient assistance (not general operating)
- Financial reports must separately account for patient assistance funds
- Donor restrictions honored (if donor specifies "for genetic testing," use only for that)

### Internal Controls

**Segregation of Duties:**

- Different staff members:
  - Review applications (Patient Services Coordinator)
  - Approve assistance (Program Manager/Director)
  - Process payments (Finance Department)
  - Reconcile accounts (Controller/CFO)

**Payment Controls:**

- Dual signature required for checks >$5,000
- Electronic payment approvals require two-factor authentication
- Monthly reconciliation of patient assistance fund
- Quarterly audit of random sample of applications

**Reporting:**

- Monthly dashboard to Executive Director (applications, approvals, denials, spending)
- Quarterly report to Board Finance Committee
- Annual audit by external CPA firm

---

## Annual Budget & Allocation

### Year 1 Budget (Startup Year)

**Total Annual Budget: $630,000**

| Assistance Type              | # Patients | Avg Amount | Total Budget | % of Total |
| ---------------------------- | ---------- | ---------- | ------------ | ---------- |
| Genetic Testing              | 100        | $1,500     | $150,000     | 24%        |
| Augmentation Therapy Co-Pays | 25         | $10,000    | $250,000     | 40%        |
| Travel Assistance            | 50         | $2,000     | $100,000     | 16%        |
| Specialist Co-Pays           | 50         | $1,000     | $50,000      | 8%         |
| DME Assistance               | 15         | $2,000     | $30,000      | 5%         |
| Emergency Assistance         | 10         | $5,000     | $50,000      | 8%         |
| **Total Direct Assistance**  | **250\***  |            | **$630,000** | **100%**   |

_Note: Some patients receive multiple types of assistance, so total unique patients ~185_

**Program Administration Costs: $120,000** (16% of direct assistance)

- Patient Services Coordinator Salary: $55,000
- Program Manager Salary (50% time): $35,000
- Technology (application portal, database): $15,000
- Marketing and outreach: $10,000
- Professional fees (legal, compliance): $5,000

**Total Program Cost: $750,000** (Direct Assistance + Administration)

**Funding Sources:**

- Individual Donors: $300,000 (40%)
- Corporate/Foundation Grants: $300,000 (40%)
- Fundraising Events: $100,000 (13%)
- Board Designated Reserves: $50,000 (7%)

### Year 2-3 Growth Projections

**Year 2: $900,000 Total Budget**

- 30% increase in funding
- Serve 350 patients (increase capacity)
- Add: Liver transplant support program
- Efficiency improvements reduce admin to 14%

**Year 3: $1,200,000 Total Budget**

- 33% increase over Year 2
- Serve 500 patients
- Launch endowment campaign for sustainability
- Expand to include caregiver support grants

---

## Impact Measurement & Reporting

### Patient-Level Outcomes

**Diagnosis Impact (Genetic Testing Assistance):**

- ‚úÖ **Metric**: % of assisted patients who receive confirmed AATD diagnosis
- üéØ **Target**: >80% (some will test negative, which is also valuable information)
- üìä **Measurement**: Follow-up survey 60 days post-assistance

**Treatment Adherence (Augmentation Therapy Assistance):**

- ‚úÖ **Metric**: % of assisted patients who continue therapy for ‚â•12 months
- üéØ **Target**: >90% (vs. national average ~70% for patients without assistance)
- üìä **Measurement**: Quarterly check-ins, pharmacy refill data

**Health Outcomes:**

- ‚úÖ **Metric**: Patient-reported health status improvement (SF-36 survey)
- üéØ **Target**: ‚â•25% improvement in respiratory symptom scores
- üìä **Measurement**: Baseline and 6-month follow-up surveys

**Financial Stress Reduction:**

- ‚úÖ **Metric**: Patient-reported financial burden (validated scale)
- üéØ **Target**: 50% reduction in financial stress scores
- üìä **Measurement**: Application baseline, 3-month follow-up

### Program-Level Metrics

**Efficiency Metrics:**

- **Application Processing Time**: Average days from submission to decision (Target: ‚â§10 days)
- **Payment Speed**: Average days from approval to payment issued (Target: ‚â§5 days)
- **Administrative Cost Ratio**: Admin costs √∑ direct assistance (Target: ‚â§15%)

**Access Metrics:**

- **Application Volume**: Number of applications received (Trend: increasing awareness)
- **Approval Rate**: % of applications approved (Target: 60-70%, if too high may be under-serving need)
- **Denial Reasons**: Categorize why applications denied (improve outreach to eligible patients)

**Equity Metrics:**

- **Geographic Distribution**: Patients served by state/region (ensure rural access)
- **Racial/Ethnic Demographics**: Compare to AATD population demographics (identify disparities)
- **Income Distribution**: % served in each income tier (prioritizing lowest income)

**Satisfaction Metrics:**

- **Patient Satisfaction**: Net Promoter Score, overall satisfaction rating (Target: ‚â•9/10)
- **Ease of Application**: "The application process was easy" (Target: ‚â•80% agree)
- **Timeliness**: "I received assistance when I needed it" (Target: ‚â•85% agree)

### Annual Impact Report

**Report Contents:**

1. **Executive Summary**: Patients served, total assistance distributed, key outcomes
2. **Patient Stories**: 3-5 anonymized case studies with photos (consent obtained)
3. **Financial Summary**: Revenue sources, expenditures, efficiency ratios
4. **Outcomes Data**: Health improvements, treatment adherence, satisfaction scores
5. **Challenges & Lessons Learned**: What didn't work, how we adapted
6. **Year Ahead Goals**: Expansion plans, fundraising needs, program improvements

**Distribution:**

- Posted on website (public transparency)
- Mailed to donors who contributed to patient assistance fund
- Presented to Board of Directors
- Shared with grantmakers and corporate sponsors
- Submitted to GuideStar and Charity Navigator

---

## Appeals & Grievance Process

### How to Appeal a Denial

**Grounds for Appeal:**

- New information not included in original application
- Disagreement with eligibility determination
- Belief that application was not properly reviewed
- Change in financial circumstances since application
- Exceptional hardship circumstances

**Appeal Submission:**

- Must be submitted within **30 days** of denial notification
- Email to: appeals@markeglyfoundation.org
- Or mail to: Mark Egly Foundation, Attn: Appeals Committee, [Address]
- Include:
  - Original application ID number
  - Reason for appeal (specific)
  - New documentation supporting eligibility
  - Signed statement from patient

**Appeal Review Process:**

1. **Receipt & Acknowledgment**: Appeal logged within 2 business days
2. **Review by Appeals Committee**: 3-member panel (not involved in original decision)
   - Director of Patient Services (if not original approver)
   - Medical Advisory Board member
   - Board member or outside volunteer
3. **Additional Information**: Committee may request clarification or additional documents
4. **Decision**: Rendered within **15 business days** of complete appeal submission
5. **Final Notification**: Patient notified via email and letter

**Appeal Outcomes:**

- ‚úÖ **Approved**: Original denial overturned, assistance granted
- üîÑ **Partial Approval**: Assistance granted at reduced amount or different terms
- ‚ùå **Denied**: Original denial upheld, decision is final

**Final Decision:**

- Appeals Committee decision is **final**
- No further appeals within Foundation
- Patient may reapply if circumstances change significantly (6+ months later)

### Patient Grievance Process

**Complaints About:**

- Staff conduct (rudeness, discrimination, privacy violation)
- Application process (unfair treatment, excessive delays)
- Payment issues (incorrect amount, delayed payment)
- Program policies (belief they are unjust or harmful)

**How to File Grievance:**

- Email: patientservices@markeglyfoundation.org
- Phone: 1-800-XXX-XXXX (toll-free)
- Mail: Mark Egly Foundation, Attn: Patient Services Director, [Address]
- Anonymous option: Online form at markeglyfoundation.org/feedback

**Grievance Resolution:**

1. **Receipt**: Acknowledged within 2 business days
2. **Investigation**: Director of Patient Services reviews complaint, interviews staff
3. **Resolution Attempt**: Contact patient to understand concern and propose solution
4. **Outcome**: Resolution offered within 10 business days
5. **Escalation**: If unresolved, escalate to Executive Director

**Patient Rights:**

- File grievance without fear of retaliation
- Remain eligible for assistance regardless of complaint
- Receive timely response
- Have complaint taken seriously and investigated fairly

---

## Program Marketing & Outreach

### Target Audiences

**1. Diagnosed AATD Patients**

- Currently receiving treatment (augmentation therapy patients)
- Newly diagnosed (within past year)
- Long-term diagnosed patients facing new financial barriers

**Outreach Channels:**

- Partner with AAT manufacturers' patient education programs
- Infusion center partnerships (flyers, posters)
- AATD support groups (Alpha-1 Foundation chapters)
- Patient advocacy organization newsletters
- Social media (Facebook AATD groups)

**2. Undiagnosed Patients (For Testing Assistance)**

- COPD patients misdiagnosed (most common scenario)
- Liver disease patients of unknown etiology
- Family members of known AATD patients (carriers)
- Young adults with unexplained shortness of breath

**Outreach Channels:**

- Pulmonologist and hepatologist education (CME programs)
- COPD patient support groups
- Genetic counselor networks
- Direct-to-consumer advertising (limited budget)

**3. Healthcare Providers**

- Pulmonologists and hepatologists
- Primary care physicians
- Genetic counselors
- Hospital social workers and case managers
- Infusion nurses

**Outreach Channels:**

- Provider education materials (brochures, posters)
- Medical conference exhibits
- Peer-to-peer outreach (Medical Advisory Board members)
- Electronic health record (EHR) alerts/reminders

### Marketing Materials

**Patient-Facing:**

- **Brochure**: "Financial Help for AATD Patients" (English and Spanish)
- **One-Pager**: Eligibility quick-check and how to apply
- **Posters**: For infusion centers, clinics, hospitals
- **Social Media Graphics**: Instagram/Facebook posts about assistance available
- **Video**: Patient testimonial about how assistance changed their life

**Provider-Facing:**

- **Provider Referral Form**: Quick form to refer patients
- **Eligibility Flowchart**: Visual guide to help providers identify eligible patients
- **Case Studies**: Examples of patients helped and improved outcomes
- **Email Signature**: Providers can add "Ask me about AATD patient assistance" to signature

### Digital Marketing

**Website:**

- Prominent "Get Help" or "Financial Assistance" button on homepage
- SEO-optimized pages for "AATD patient assistance," "alpha-1 financial help," "AAT therapy co-pay help"
- Chatbot to answer common questions and direct to application

**Social Media:**

- Weekly posts about patient assistance program
- Patient stories (with consent) showing impact
- "Did you know?" education about financial resources
- Live Q&A sessions with Patient Services staff

**Email Campaigns:**

- Monthly newsletter to patient database highlighting assistance available
- Targeted campaigns to newly diagnosed patients
- Reminders to reapply (for patients who received 1-year assistance)

**Paid Advertising:**

- Google Grants ($10,000/month free advertising for nonprofits)
- Facebook/Instagram ads targeted to AATD patients and caregivers
- Search ads for "AATD financial help," "can't afford AAT therapy"

### Partnerships for Awareness

**Alpha-1 Foundation:**

- Cross-promote patient assistance programs
- Share resources and referrals
- Joint webinars on navigating financial challenges

**Pharmaceutical Companies:**

- Include Foundation information in patient starter kits
- Train patient liaisons to refer to Foundation when PAP doesn't cover need
- Co-branded materials (within ethical guidelines)

**Healthcare Systems:**

- Hospital financial counselors trained on Foundation assistance
- Referral agreements with major AATD treatment centers
- Lunch-and-learns for case managers and social workers

---

## Success Stories & Testimonials

### Patient Story Example (Anonymized)

**Sarah's Story: From Diagnosis to Hope**

_"I coughed for 15 years before anyone tested me for Alpha-1. When I finally got diagnosed, I was relieved to have an answer‚Äîbut terrified about the cost. The genetic testing alone was $800 out-of-pocket, and my doctor said I'd need weekly IV infusions costing thousands per month. I'm a single mom; there was no way I could afford it._

_Then my doctor told me about the Mark Egly Foundation. I was skeptical‚ÄîI've never been good at asking for help‚Äîbut I filled out the application. Within two weeks, they approved me for genetic testing assistance AND help with my therapy co-pays. They paid the lab directly for my test, and now they help cover $800/month of my infusion costs._

_For the first time in months, I can breathe‚Äîliterally and figuratively. I'm not lying awake at night worrying about how to pay for my medication. My lung function is improving, and I can play with my kids again. This foundation gave me my life back."_

‚Äî Sarah M., Texas (Patient #042, Genetic Testing + Therapy Assistance, $12,200 total)

### Measuring Impact Beyond Numbers

**Qualitative Outcomes:**

- Patient reports "peace of mind" and reduced anxiety
- Improved family relationships (less financial stress at home)
- Ability to continue working (therapy prevents disability)
- Increased engagement in patient advocacy (gratitude turns to activism)
- Generational impact (parents treated can raise children, see grandchildren)

**Provider Testimonials:**

- Pulmonologists: "Having financial assistance available means I can prescribe optimal therapy without worrying about affordability"
- Social workers: "This foundation is a lifeline for my patients who fall through the cracks"
- Genetic counselors: "I always recommend testing, but many patients couldn't afford it until this program"

---

## Continuous Improvement

### Annual Program Review

**Review Team:**

- Director of Patient Services (leads)
- Program Manager
- Patient Services Coordinator
- Finance Director
- 2-3 patients who received assistance (patient advisory role)
- 1 Medical Advisory Board member

**Review Components:**

1. **Data Analysis**: Review all metrics (applications, approvals, denials, outcomes)
2. **Patient Feedback**: Survey of assisted patients about experience and suggestions
3. **Staff Feedback**: What's working, what's challenging, ideas for improvement
4. **Financial Review**: Budget vs. actual, sustainability assessment
5. **Policy Review**: Are eligibility criteria appropriate? Should assistance amounts change?
6. **Benchmarking**: Compare to other patient assistance programs (CF Foundation, NORD, etc.)

**Outcome:**

- Updated policies and procedures
- Budget adjustments for next fiscal year
- New partnerships or programs identified
- Technology improvements planned
- Staff training needs addressed

### Patient Advisory Committee

**Purpose**: Include patient voice in program design and evaluation

**Composition**:

- 5-7 AATD patients (diverse demographics, disease stages, geographic locations)
- Mix of patients who have received assistance and those who haven't
- Appointed for 2-year terms (staggered)

**Responsibilities:**

- Meet quarterly (virtual meetings)
- Review application process and provide feedback
- Suggest improvements to patient experience
- Help develop patient-facing materials
- Share patient assistance information in their networks
- Participate in annual program review

**Compensation:**

- $100 stipend per meeting (3 hours)
- Honorarium for major contributions (testifying to Board, developing materials)

### Technology Enhancements (Roadmap)

**Year 1:**

- ‚úÖ Online application portal (HIPAA-compliant)
- ‚úÖ Patient portal for status tracking
- ‚úÖ Basic database for application management

**Year 2:**

- üîÑ Integration with electronic health records (EHRs) for provider referrals
- üîÑ Mobile app for application submission
- üîÑ Automated eligibility screening (reduces staff workload)
- üîÑ SMS text notifications for application updates

**Year 3:**

- üîÆ AI chatbot for answering common questions 24/7
- üîÆ Predictive analytics to identify patients at risk of dropping out of treatment
- üîÆ Integration with patient registry for long-term outcomes tracking
- üîÆ Virtual reality "application assistance" for patients with limited literacy

---

## Conclusion

The Mark Egly Foundation Patient Assistance Program embodies our core mission: ensuring that no AATD patient is prevented from diagnosis or treatment due to financial barriers. By providing comprehensive, dignified, and sustainable assistance, we not only change individual lives but advance health equity for the entire AATD community.

**Core Commitments:**

- ‚úÖ Every eligible patient receives assistance
- ‚úÖ Dignity and respect in every interaction
- ‚úÖ Transparent and accountable use of donor funds
- ‚úÖ Continuous improvement based on patient feedback
- ‚úÖ Collaboration with industry and advocacy partners
- ‚úÖ Long-term sustainability through diversified funding

**Call to Action:**
If you are struggling to afford AATD testing or treatment, please apply. If you know someone who could benefit, please share this information. If you want to support this program, please donate or volunteer.

Together, we can ensure that financial barriers never stand between an AATD patient and the care they need.

---

**For More Information:**

- Website: markeglyfoundation.org/patient-assistance
- Phone: 1-800-XXX-XXXX (toll-free, M-F 9am-5pm ET)
- Email: patientservices@markeglyfoundation.org
- Application Portal: markeglyfoundation.org/apply

---

**Document Control:**

- **Version**: 1.0
- **Approved By**: Board of Directors, [Date]
- **Next Review**: November 2026
- **Document Owner**: Director of Patient Services
- **Related Policies**: Financial Assistance Policy, HIPAA Privacy Policy, Fundraising Policy

_Mark Egly Foundation | Patient Assistance Program | November 10, 2025_
